Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerrold F Rosenbaum

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Focus (American Psychiatric Publishing)|October 25, 2021
Anxiety Treatment With BenzodiazepinesJerrold F Rosenbaum
The Journal of Clinical Psychiatry|August 28, 2024
Functional Unblinding in Pivotal Studies and the Future of Psychedelic MedicineJerrold F Rosenbaum
Depression and Anxiety|March 31, 2011
Recollections from the ADAA PresidentJerrold F Rosenbaum
The American Journal of Psychiatry|June 2, 2020
Benzodiazepines: A PerspectiveJerrold F Rosenbaum
The Journal of Clinical Psychiatry|April 14, 2004
The development of clonazepam as a psychotropic: the massachusetts general hospital experienceJerrold F Rosenbaum
The Journal of Clinical Psychiatry|March 15, 2005
Attitudes toward benzodiazepines over the yearsJerrold F Rosenbaum
CNS Spectrums|May 8, 2004
Conclusion: the future of single-isomer pharmacologyJerrold F Rosenbaum
Current Opinion in Psychiatry|June 4, 2010
Risk factors for fatal and nonfatal repetition of suicide attempt: a critical appraisalMassimiliano Beghi, Jerrold F Rosenbaum
Dialogues in Clinical Neuroscience|October 29, 2011
Placebo response in depressionShamsah B Sonawalla, Jerrold F Rosenbaum
CNS Spectrums|May 8, 2004
Escitalopram: a second-generation SSRIMichael J Owens, Jerrold F Rosenbaum
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Focus (American Psychiatric Publishing)|October 25, 2021
Anxiety Treatment With BenzodiazepinesJerrold F Rosenbaum
The Journal of Clinical Psychiatry|August 28, 2024
Functional Unblinding in Pivotal Studies and the Future of Psychedelic MedicineJerrold F Rosenbaum
Depression and Anxiety|March 31, 2011
Recollections from the ADAA PresidentJerrold F Rosenbaum
The American Journal of Psychiatry|June 2, 2020
Benzodiazepines: A PerspectiveJerrold F Rosenbaum
The Journal of Clinical Psychiatry|April 14, 2004
The development of clonazepam as a psychotropic: the massachusetts general hospital experienceJerrold F Rosenbaum
The Journal of Clinical Psychiatry|March 15, 2005
Attitudes toward benzodiazepines over the yearsJerrold F Rosenbaum
CNS Spectrums|May 8, 2004
Conclusion: the future of single-isomer pharmacologyJerrold F Rosenbaum
Current Opinion in Psychiatry|June 4, 2010
Risk factors for fatal and nonfatal repetition of suicide attempt: a critical appraisalMassimiliano Beghi, Jerrold F Rosenbaum
Dialogues in Clinical Neuroscience|October 29, 2011
Placebo response in depressionShamsah B Sonawalla, Jerrold F Rosenbaum
CNS Spectrums|May 8, 2004
Escitalopram: a second-generation SSRIMichael J Owens, Jerrold F Rosenbaum
Pageof 9